Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: Results from the European community respiratory health survey

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Voll Aanerud, Marianne ^a,b   Eagan, Tomas M L ^a,c   Plana, Estel ^b   Omenaas, Ernst R ^a,c   Bakke, Per S ^a,c   Svanes, Cecilie ^a   Siroux, Valerie ^d   Pin, Isabelle ^d   Antó, Josep M ^b,e   Leynaert, Benedicte ^f  

^a UNIVERSITY OF BERGEN   (Norway)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; ATOPY; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COUGHING; DYSPNEA; EUROPEAN UNION; FEMALE; HEALTH SURVEY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SMOKING; WHEEZING;

ADULT; ASTHMA; EUROPE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77957148010     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-107     Document Type: Article

References (36)

1. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996, 9:687-695. 10.1183/09031936.96.09040687, 8726932.
2. Eagan TM, Bakke PS, Eide GE, Gulsvik A. Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study. Eur Respir J 2002, 19:599-605. 10.1183/09031936.02.00247302, 11998986.
3. Lundback B, Stjernberg N, Nystrom L, Forsberg B, Lindstrom M, Lundback K, Jonsson E, Rosenhall L. Epidemiology of respiratory symptoms, lung function and important determinants. Report from the Obstructive Lung Disease in Northern Sweden Project. Tuber Lung Dis 1994, 75:116-126. 10.1016/0962-8479(94)90040-X, 8032044.
4. Frostad A, Soyseth V, Haldorsen T, Andersen A, Gulsvik A. Respiratory symptoms and long-term cardiovascular mortality. Respir Med 2007, 101:2289-2296. 10.1016/j.rmed.2007.06.023, 17681463.
5. Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med 2008, 102:399-406. 10.1016/j.rmed.2007.10.012, 18061422.
6. Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008, 63:768-774. 10.1136/thx.2007.093724, 18505800.
7. de Marco R, Accordini S, Cerveri I, Corsico A, Anto JM, Kunzli N, Janson C, Sunyer J, Jarvis D, Chinn S, Vermeire P, Svanes C, Ackermann-Liebrich U, Gislason T, Heinrich J, Leynaert B, Neukirch F, Schouten JP, Wjst M, Burney P. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007, 175:32-39. 10.1164/rccm.200603-381OC, 17008642.
8. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996, 153:1530-1535.
9. Fujimura M, Nishizawa Y, Nishitsuji M, Nomura S, Abo M, Ogawa H. Predictors for typical asthma onset from cough variant asthma. J Asthma 2005, 42:107-111. 10.1081/JAS-51336, 15871442.
10. Sistek D, Wickens K, Amstrong R, D'Souza W, Town I, Crane J. Predictive value of respiratory symptoms and bronchial hyperresponsiveness to diagnose asthma in New Zealand. Respir Med 2006, 100:2107-2111. 10.1016/j.rmed.2006.03.028, 16730967.
11. Frostad A, Soyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006, 259:520-529. 10.1111/j.1365-2796.2006.01631.x, 16629856.
12. Hu J, Meek P. Health-related quality of life in individuals with chronic obstructive pulmonary disease. Heart Lung 2005, 34:415-422. 10.1016/j.hrtlng.2005.03.008, 16324961.
13. Polley L, Yaman N, Heaney L, Cardwell C, Murtagh E, Ramsey J, Macmahon J, Costello RW, McGarvey L. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest 2008, 134:295-302. 10.1378/chest.07-0141, 18071022.
14. Schatz M, Mosen D, Apter AJ, Zeiger RS, Vollmer WM, Stibolt TB, Leong A, Johnson MS, Mendoza G, Cook EF. Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol 2005, 115:1049-1055. 10.1016/j.jaci.2005.02.008, 15867865.
15. Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2005, 2:183-191. 10.1191/1479972305cd079oa, 16541601.
16. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008, 63:402-407. 10.1136/thx.2007.085456, 18234906.
17. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005, 9:926-932.
18. Raherison C, Abouelfath A, Le Gros V, Taytard A, Molimard M. Underdiagnosis of nocturnal symptoms in asthma in general practice. J Asthma 2006, 43:199-202. 10.1080/02770900600566744, 16754521.
19. Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Changes in respiratory symptoms and health-related quality of life. Chest 2007, 131:1890-1897. 10.1378/chest.06-2629, 17505046.
20. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994, 7:954-960.
21. The European Community Respiratory Health Survey II. Eur Respir J 2002, 20:1071-1079. 10.1183/09031936.02.00046802, 12449157.
22. Aaronson NK, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M, Bungay K, Fukuhara S, Gandek B, Keller S, et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1992, 1:349-351. 10.1007/BF00434949, 1299467.
23. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's manual. 1994,
24. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000, 162:1391-1396.
25. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001, 46:798-825.
26. Jarvis D, Luczynska C, Chinn S, Potts J, Sunyer J, Janson C, Svanes C, Kunzli N, Leynaert B, Heinrich J, Kerkhof M, Ackermann-Liebrich U, Anto JM, Cerveri I, de Marco R, Gislason T, Neukirch F, Vermeire P, Wjst M, Burney P. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J Allergy Clin Immunol 2005, 116:675-682. 10.1016/j.jaci.2005.05.009, 16159642.
27. StataCorp Stata Statistical Software, InCollege Station, TX, StataCorp.
28. Stavem K, Lossius MI, Kvien TK, Guldvog B. The health-related quality of life of patients with epilepsy compared with angina pectoris, rheumatoid arthritis, asthma and chronic obstructive pulmonary disease. Qual Life Res 2000, 9:865-871. 10.1023/A:1008993821253, 11297029.
29. Wang HM, Beyer M, Gensichen J, Gerlach FM. Health-related quality of life among general practice patients with differing chronic diseases in Germany: cross sectional survey. BMC Public Health 2008, 8:246. 10.1186/1471-2458-8-246, 2515099, 18638419.
30. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991, 46:863-870. 10.1136/thx.46.12.863, 463489, 1792631.
31. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001, 164:372-377.
32. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005, 60:842-847. 10.1136/thx.2005.043943, 1747202, 16085729.
33. Boot CR, van der Gulden JW, Vercoulen JH, van den Borne BH, Orbon KH, Rooijackers J, van Weel C, Folgering HT. Knowledge about asthma and COPD: associations with sick leave, health complaints, functional limitations, adaptation, and perceived control. Patient Educ Couns 2005, 59:103-109. 10.1016/j.pec.2004.10.007, 16198224.
34. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990, 142:1009-1014.
35. Simon PM, Schwartzstein RM, Weiss JW, Lahive K, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989, 140:1021-1027.
36. Garcia-Marcos L, Carvajal Uruena I, Escribano Montaner A, Fernandez Benitez M, Garcia de la Rubia S, Tauler Toro E, Perez Fernandez V, Barcina Sanchez C. Seasons and other factors affecting the quality of life of asthmatic children. J Investig Allergol Clin Immunol 2007, 17:249-256.